Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v12-EN
Language English English
Date Updated 2023-01-19 2023-01-10
Drug Identification Number 00502790 00502790
Brand name COTAZYM ECS 8 COTAZYM ECS 8
Common or Proper name PANCRELIPASE DELAYED-RELEASE CAPSULES PANCRELIPASE DELAYED-RELEASE CAPSULES
Company Name ORGANON CANADA INC. ORGANON CANADA INC.
Ingredients PROTEASE AMYLASE LIPASE PROTEASE AMYLASE LIPASE
Strength(s) 45000UNIT 42000UNIT 10800UNIT 45000UNIT 42000UNIT 10800UNIT
Dosage form(s) CAPSULE (DELAYED RELEASE) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 500 500
ATC code A09AA A09AA
ATC description DIGESTIVES, INCL ENZYMES DIGESTIVES, INCL ENZYMES
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2022-11-07 2022-11-07
Actual start date 2022-10-26 2022-10-26
Estimated end date 2023-02-24 2023-02-24
Actual end date 2023-01-18
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments